Novo Nordisk (NVO) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

68
on a 30–98 scale
HOLD
$40.65last close
+1score vs prior day
34–92range since 06-29
-15.9%price since 06-29

The entry score measures one thing: how far Novo Nordisk's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Novo Nordisk's price sits 0.82 ATR above its 20-day average ($39.83); it trades below its 200-day average ($43.27); its 14-day RSI is 58; it has moved +4.69% over 20 sessions; our regime filter classifies it as no confirmed trend.

Is Novo Nordisk (NVO) a buy right now?

Novo Nordisk scores 68/98 (Hold) as of 2026-11-12; it is 36.5% below its 52-week high of $63.98; it is below its 200-day average; it moved +0.84% over the last 5 sessions. A mid-range score means the price is near its recent average: not a stretched entry, not a discount. Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1268+1$40.65
2026-11-0667+2$40.31
2026-11-0565+31$40.30
2026-11-0434-30$42.18
2026-11-0364+6$40.19
2026-11-0258-15$40.45
2026-10-2973-3$39.14
2026-10-2876+2$38.29
2026-10-2774+7$38.67
2026-10-2667-1$39.13
2026-10-2368+2$39.05
2026-10-2266-3$39.43

Congress trades in NVO

STOCK Act disclosures by members of Congress, cross-referenced from our Smart Money tracker.

TradedPoliticianTypeAmountReturn since
2026-09-10Kevin Hern (R)SALE$1,001 - $15,000-8.4%
2026-08-31Kevin Hern (R)SALE$1,001 - $15,000-11.1%
2026-08-26Scott Scott Franklin (R)BUY$1,001 - $15,000-14.6%

Our analysis mentioning Novo Nordisk

Related stocks

See today's full rankings + entry plan for NVO →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.